Last checked at 3 Apr 2017 11:26
Surgical Innovations Group plc
("the Company")
Director/PDMR Shareholding
The Company was notified on 31 March 2017 that on that day, Melanie Ross, Chief Operating Officer, disposed of 605,714 ordinary shares of 1 penny each ("Shares") at a price of 3.55p per share.
In addition, Melanie Ross purchased 340,714 ordinary shares for her ISA and her husband, Lee Ross purchased 265,000 ordinary shares for his ISA, at a price of 3.555p per share.
Additionally, on the same day Melanie Ross transferred 265,000 ordinary shares to Lee Ross for nil
consideration.
Following the transactions, there has been no change to the combined beneficial holding of Melanie Ross and her husband in the Company and has remained at 1,240,377 shares, representing approximately 0.23% of the issued share capital of the Company.
The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on shares acquired.
For further information please contact:
Surgical Innovations Group Plc | www.sigroupplc.com | |
Nigel Rogers, Executive Chairman | Tel: 0113 230 7597 | |
Melanie Ross, COO & Finance Director | ||
WH Ireland Limited (NOMAD & Broker) | ||
Tim Feather
| Tel: 0113 394 6600
| |
Walbrook PR (Financial PR & Investor Relations) | Tel: 020 7933 8780 or si@walbrookpr.com | |
Paul McManus | Mob: 07980 541893 | |
1 | Details of the person discharging managerial responsibilities/person closely associated | ||||||||||
a) | Name | Melanie Ross | |||||||||
2 | Reason for the notification | ||||||||||
a) | Position/status | Chief Operating Officer, Surgical Innovations Group plc | |||||||||
b) | Initial notification/ Amendment | Initial Notification | |||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||||||
a) | Name | Surgical Innovations Group plc | |||||||||
b) | LEI | N/A | |||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1p
GB0004016704
| |||||||||
b) | Nature of the transactions | 1. Sale of shares 2. Transfer of shares to husband
| |||||||||
c) | Price(s) and volume(s) |
| |||||||||
d) | Aggregated information - Aggregated volume - Price |
As per 4(c) above | |||||||||
e) | Date of the transaction | 31 March 2017 | |||||||||
f) | Place of the transaction | London Stock Exchange, AIM | |||||||||
1 | Details of the person discharging managerial responsibilities/person closely associated | ||||||||||
a) | Name | Melanie Ross | |||||||||
2 | Reason for the notification | ||||||||||
a) | Position/status | Chief Operating Officer, Surgical Innovations Group plc | |||||||||
b) | Initial notification/ Amendment | Initial Notification | |||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||||||
a) | Name | Surgical Innovations Group plc | |||||||||
b) | LEI | N/A | |||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1p
GB0004016704
| |||||||||
b) | Nature of the transactions | 1. Purchase of shares in ISA 2. Purchase of shares by husband
| |||||||||
c) | Price(s) and volume(s) |
| |||||||||
d) | Aggregated information - Aggregated volume - Price |
605,714 £21,533 | |||||||||
e) | Date of the transaction | 31 March 2017 | |||||||||
f) | Place of the transaction | London Stock Exchange, AIM | |||||||||